Literature DB >> 9236874

The development of a Marjolin's cancer in a human immunodeficiency virus-positive hemophilic man and review of the literature.

A Rahimizadeh1, R Shelton, H Weinberg, N Sadick.   

Abstract

BACKGROUND: The malignant potential of chronic ulcers and scars secondary to a variety of injuries is well characterized in the medical literature. Furthermore, it has been reported that human immunodeficiency virus (HIV)-positive patients have a higher incidence of basal cell carcinoma (BCC) than the general population.
OBJECTIVE: To describe a case of an unusually aggressive morpheaform BCC that developed in a 28-year-old HIV-positive patient. The tumor developed in a scar 25 years after the initial trauma (Marjolin's ulcer).
METHODS: Description of a case and review of the literature of Marjolins ulcer.
RESULTS: The tumor was removed in a seven-stage, 21-section, micrographically controlled excision. Intraoperatively, perineural invasion of the infraorbital nerve was observed. The postoperative defect was repaired using a full-thickness skin graft.
CONCLUSION: Although most malignancies arising within chronic scars are SCCs, BCCs and a number of other tumors have been described. Mohs micrographic surgery was effective in treating this aggressive morpheaform BCC. A high degree of suspicion in any changing healed scar is recommended.

Entities:  

Mesh:

Year:  1997        PMID: 9236874     DOI: 10.1111/j.1524-4725.1997.tb00687.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  2 in total

Review 1.  [Not Available].

Authors:  S Ouahbi; H Droussi; S Boukind; M Dlimi; O K Elatiqi; M D Elamrani; Y Benchamkha; S Ettalbi
Journal:  Ann Burns Fire Disasters       Date:  2013-12-31

2.  Neglected basal cell carcinoma presenting with diffuse skeletal metastases.

Authors:  Nour Kibbi; Vivian Ortiz; Sara H Perkins; Rebecca J Baldassarri; Suguru Imaeda; Jürgen L Holleck
Journal:  JAAD Case Rep       Date:  2018-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.